Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Malaysia’s National Pharmaceutical Regulatory Division (NPRA) is also currently evaluating the CanSino single-dose Covid-19 vaccine. Earlier, it was reported that Malaysia will receive a supply of 3.5 million doses of the CanSino Covid-19 vaccine from China in stages, starting from April